Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. - Wikidata - awgldk - TriplyDB

Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers.

Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers.

http://www.wikidata.org/entity/Q39661923

about

Biosafe nanoscale pharmaceutical adjuvant materials Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems Nanoparticle "switch-on" by tetrazine triggering Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Stimuli-responsive nanomaterials for biomedical applications Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.Lectin-gated, mesoporous, photofunctionalized glyconanoparticles for glutathione-responsive drug delivery.Redox-Triggered Release of Moxifloxacin from Mesoporous Silica Nanoparticles Functionalized with Disulfide Snap-Tops Enhances Efficacy Against Pneumonic Tularemia in Mice.Photon-manipulated drug release from a mesoporous nanocontainer controlled by azobenzene-modified nucleic acid Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.Cetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistance Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide.Multifunctional nanoparticles for multimodal imaging and theragnosis.Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.Mesoporous silica nanoparticles in nanotechnology.Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.Electrospun nanofibers-mediated on-demand drug release.Stimuli-responsive cancer therapy based on nanoparticles.Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response to chemical, physical and biological stimuli.Carboxylated pillar[5]arene-coated gold nanoparticles with chemical stability and enzyme-like activity.Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.A mesoporous nanocontainer gated by a stimuli-responsive peptide for selective triggering of intracellular drug release.A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.An iGlu receptor antagonist and its simultaneous use with an anticancer drug for cancer therapy.Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.pH- and redox-responsive poly(ethylene glycol) and cholesterol-conjugated poly(amido amine)s based micelles for controlled drug delivery.A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery.Recent Advance on Mesoporous Silica Nanoparticles-Based Controlled Release System: Intelligent Switches Open up New Horizon.One-step photo synthesis of protein-drug nanoassemblies for drug delivery.Stimuli-Responsive Polymeric Nanoparticles.Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells.pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs.Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics.Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells.Photo-redox activated drug delivery systems operating under two photon excitation in the near-IR.

P2860

Q26829798-DAFBD647-EBB7-40ED-A482-9A1B8E14C89E Q28822460-A59B700F-3CFD-4DE6-A30A-1EEDEA565C79 Q28822555-26DFC381-1057-4ACC-8B49-421DC3631F69 Q30361646-BAF3EC15-9063-44E4-A43D-B88A6ECE1500 Q30362001-A71D6CC7-0948-41A0-8978-DA6844639CBB Q30396768-E070D42D-EBDC-4717-A66C-7C6FF294F245 Q35154383-68CF4AF7-1FD6-4A23-A98C-92A1AA369658 Q35685391-6DA11A7C-75ED-4972-B8DB-0C11900059FB Q36035473-F6BF47B2-E5B2-4B9F-9C9C-079D31CE9972 Q36124921-D9CAC6A7-C1BE-4FBC-B0BD-3FA14014A87C Q36328315-946735AC-5883-4D0A-85F9-6CB939554D43 Q36875298-DC0DA225-BD1C-49F9-9BE0-8140BF562575 Q37538055-7C5E38B4-3A50-4279-9B2F-7588309EAB56 Q37735009-539C99CA-24F9-46CD-9AE9-B994EDB1D83E Q37970569-B19E56D9-3D6E-4EE8-8AF7-3B78ED78A057 Q37989408-1D141A54-FE60-43B2-9B37-8022E49CED63 Q38020874-79B58FAE-37DE-4B83-9AEA-173304E4C3D3 Q38133484-EEC184C4-25C2-4D61-BD62-304DB2AE9116 Q38217153-04A47F0E-974F-4DCF-98BF-B765F39DE6FC Q38233457-7F7FCBDC-4EF9-40FE-A528-0A1271386ADA Q38271137-0942644B-4250-4898-854D-3FFE4F1C3E98 Q38353035-8A18A990-7059-4509-B081-D29744A2A94A Q38435175-17E992FB-6AE5-44C6-9BF5-51D9CC0440F8 Q38665073-C3D1FFCC-EAB1-46D3-BBB6-98E73645B408 Q38782759-D65E4044-AECC-48CA-A9DF-52FFF7D4CBE2 Q38874416-6693446A-5B4C-4F94-AEFC-782D4AF32F90 Q38883912-8EC943AC-7857-4180-BA77-33F16D392823 Q38904231-2154CD00-BD43-4A81-99D6-C5BF260E8F44 Q38973607-CAB42ED0-ADE1-4D99-89C5-7933EBED9D42 Q39084245-272A12F1-899E-43D8-B680-BB5EC730EA25 Q39084260-BDD3D9E8-E9EB-4EDB-A782-D1C733B2E894 Q39117681-5E275945-22E8-4EA8-BB73-72E98B1F1018 Q39202711-C3DB6E22-DDCB-40D5-8B93-42EFF4856188 Q39214920-9723BAC3-E6AF-4088-93A2-5EA56998B237 Q39301880-3AECD8FC-3CDB-45C7-A62B-4419B5A733C4 Q39459369-DBABC681-FEBE-4110-B122-29634D985845 Q39492946-988BC476-51D0-4E06-B6C6-62D21B7A228F Q42815680-2BA895D5-AF78-4AC0-9C21-FD16123ED202 Q42826162-4B13CE35-426E-4DF7-82CC-3EF836CAED34 Q43118050-9420A1CA-81DF-4DEC-9EB2-583066D03236

P2860

Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers.

http://www.wikidata.org/entity/Q39661923

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@en

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@nl

type

label

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@en

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@nl

prefLabel

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@en

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@nl

P1433

Q39661923-EAF4FA4A-8D4E-45A9-87BD-16303A7FC7CE

P1476

Q39661923-A71E2D67-1EAE-45A3-BF49-317FF1CF5034

P2093

Q39661923-0F318522-20C2-48EE-9250-9724733A1140

Q39661923-6695523C-ED9C-4236-A9C7-E9A0DB9AA6CE

Q39661923-68277DB9-524F-409C-9622-C2327F7197D4

Q39661923-6A961900-E38A-4CF8-AFF2-F88C9C3B0A26

Q39661923-9F10402C-381E-4922-96DD-C206A4F28295

Q39661923-B8B35F3F-AAAC-48D2-8619-A490B1C834B2

P2860

Q39661923-01B952E7-3E67-4EAB-AEBC-91AE58435203

Q39661923-03A0242F-8DDD-4A7B-B551-E2B5639B157B

Q39661923-04F2B88F-AC2D-4330-BEE1-029C52E6E1DF

Q39661923-0CB8CA60-EADE-45FC-B7EC-14EE29A6DA1F

Q39661923-184CD04F-3837-4168-8652-8935B9842A6F

Q39661923-1A3CD1C9-78D6-4120-8D74-0360B03B63D8

Q39661923-2276E005-C7A1-4CAB-88B1-BB0FC1C96F9E

Q39661923-39AB61F8-409E-4698-87FE-72AF8E2034A4

Q39661923-4DC718E6-78CB-47E5-9967-5FA5F2C88082

Q39661923-5D1CA243-EBA5-4EA7-87B6-E648D9F1549B

P304

Q39661923-2FE812A6-383C-4AC5-905B-DC3699F287D9

P31

Q39661923-65B1AF1E-5173-4EF3-B405-00AE09166C77

P356

Q39661923-3E2FD3FB-90F1-496F-A920-2563E3DD0519

P407

Q39661923-9F9BBA0B-A52F-4438-80C3-1A228725F55D

P433

Q39661923-2E004223-3D4B-49DD-B10D-2504730F5996

P478

Q39661923-7A821ACB-5A14-451E-A7BF-D4455643D67B

P577

Q39661923-1CF13D73-54E7-4DE6-8067-EF81A249B22C

P5875

Q39661923-7C3B8D50-859C-45FB-A1E0-F050A9A74704

P698

Q39661923-2FB368A5-520D-4BB0-8796-732E4B360DAF

P356

P1433

Advanced Materials

P1476

Glutathione-induced intracellu ...... with cyclodextrin gatekeepers.

@en

P2093

Chiyoung Park

http://www.w3.org/2001/XMLSchema#string

Chulhee Kim

http://www.w3.org/2001/XMLSchema#string

Heon Joo Park

http://www.w3.org/2001/XMLSchema#string

Hyehyeon Kim

http://www.w3.org/2001/XMLSchema#string

Hyemi Lee

http://www.w3.org/2001/XMLSchema#string

Saehee Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release

A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent

Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers.

Mechanised nanoparticles for drug delivery.

New cyclodextrin bioconjugates for active tumour targeting.

Controlled delivery systems using antibody-capped mesoporous nanocontainers.

Enzyme-responsive snap-top covered silica nanocontainers.

Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica.

A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes.

P304

4280-4283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ADMA.201001417

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46037830

http://www.w3.org/2001/XMLSchema#string

P698

20803535

http://www.w3.org/2001/XMLSchema#string